Effect of Astragalus membranaceus in Ovalbumin-Induced Allergic Rhinitis Mouse Model.
Zhong Bing,
Du Jin-Tao,
Liu Feng,
Luo Ba,
Liu Ya-Feng
et al.
Other
American journal of rhinology & allergy
2019
10 citations
TL;DR
AM could reduce the secretion of inflammatory cytokines by increasing the level of CD4+ CD25+ Foxp3+ T cells and inhibiting the activation of the NF-κB and have no significant effect on mRNA of IκBα.
Used In Evidence Reviews
Similar Papers
Phytotherapy research : PTR · 2010
Efficacy and safety of Astragalus membranaceus in the treatment of patients with seasonal allergic rhinitis.
61 citations
Journal of pharmaceutical and biomedical analysis · 2017
Metabolic profiling of the traditional Chinese medicine formulation Yu Ping Feng San for the identification of constituents relevant for effects on expression of TNF-α, IFN-γ, IL-1β and IL-4 in U937 cells.
36 citations
Open Access
Journal of medicinal food · 2021
Astragalus Polysaccharides Attenuate Ovalbumin-Induced Allergic Rhinitis in Rats by Inhibiting NLRP3 Inflammasome Activation and NOD2-Mediated NF-κB Activation.
32 citations
American journal of rhinology & allergy · 2022
Astragalus Polysaccharide Relieves Inflammatory Responses in Guinea Pigs with Allergic Rhinitis via Ameliorating NF-kB-Mediated Treg/Th17 Imbalance.
25 citations
Frontiers in pharmacology · 2020
Astragalus Polysaccharides/Chitosan Microspheres for Nasal Delivery: Preparation, Optimization, Characterization, and Pharmacodynamics.
21 citations
Open Access
Molecular medicine reports · 2017
Protective effects of astragaloside IV against ovalbumin-induced allergic rhinitis are mediated by T-box protein expressed in T cells/GATA-3 and forkhead box protein 3/retinoic acid-related orphan nuclear receptor γt.
21 citations
Open Access